... if Ngio will be listed (.... when? ..) at $ 5 or more and at the same time there will be interest from funds / institutional / big pharma (obviously at the base there must be positive and documentable results on the vaccine, on ae37, on the li-key platform), it is possible that the pps will go up even if many beneficiaries of the dividend will sell

..... The next cc will be fundamental: it is forbidden to make mistakes by repeating the trend of the last one ..